Literature DB >> 30831632

[Minimal residual disease before post-remission therapy predicts outcomes in younger adult with intermediate-risk acute myeloid leukemia].

Y Zhang1, Y M Zhang, Q Chen, G S Tang, H Y Qiu, L Gao, J Chen, X Ni, L Chen, W P Zhang, J M Yang, J M Wang, X X Hu.   

Abstract

Entities:  

Year:  2019        PMID： 30831632     DOI： 10.3760/cma.j.issn.0253-2727.2019.02.011

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  [Effect of consolidation before allogeneic hematopoietic stem cell transplantation for non-favorable acute myeloid leukemia patients with first complete remisson and negative minimal residual disease].

Authors:  Y M Zhang; Y Zhang; X Ni; L Gao; H Y Qiu; Y S Zhang; G S Tang; J Chen; W P Zhang; J M Wang; J M Yang; X X Hu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-01-14

2.  [Combination of interferon alpha-1b, interleukin-2 and thalidomide as maintenance therapy on acute myeloid leukemia patients with negative minimal residual disease].

Authors:  L Chen; G P Li; R H Mi; F F Yuan; H Ai; Q Wang; Z F Wang; G J Wang; R H Fan; Q S Yin; X D Wei
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.